Status:
COMPLETED
Trial of Injected Liposomal Bupivacaine vs Bupivacaine Infusion After Surgical Stabilization of Rib Fractures
Lead Sponsor:
Denver Health and Hospital Authority
Conditions:
Drug Effect
Rib Fractures
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
Rib fractures represent a common injury pattern this is highly associated with patient morbidity and mortality, as pain control remains a challenge. Even after surgical stabilization of rib fractures ...
Detailed Description
Rib fractures represent a common injury pattern with high associated morbidity and mortality. Effective pain control in both the acute and long term periods remains a challenge. Surgical stabilization...
Eligibility Criteria
Inclusion
- Patients undergoing SSRF at Denver Health Medical Center
Exclusion
- Allergy or hypersensitivity to bupivacaine
- Pregnancy
- Incarceration
- Age \< 18 years
- Indwelling continuous thoracic epidural analgesia
Key Trial Info
Start Date :
October 5 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 31 2021
Estimated Enrollment :
36 Patients enrolled
Trial Details
Trial ID
NCT03305666
Start Date
October 5 2017
End Date
January 31 2021
Last Update
September 29 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Denver Health
Denver, Colorado, United States, 80204